Group 1: Joint Venture Announcement - Suzano S.A. and Kimberly-Clark Corporation are forming a $3.4 billion joint venture to manufacture consumer and professional tissue products, with Suzano owning 51% and Kimberly-Clark holding 49% [1][7] - The joint venture will be incorporated in the Netherlands and will operate 22 manufacturing facilities across 14 countries, with an annual tissue production capacity of approximately 1 million tons and projected net sales of $3.3 billion in 2024 [2][3][7] Group 2: Market and Employment Impact - The joint venture will market and distribute various tissue products in over 70 countries and is expected to create more than 9,000 job opportunities [3] - The transaction is anticipated to close in mid-2026, with Suzano set to pay $1.734 billion in cash at closing, subject to standard post-closing adjustments [4][7] Group 3: Suzano's Financial Performance - In Q1 2025, Suzano reported net sales of $1.97 billion, an increase from $1.91 billion in the same quarter of the previous year, with adjusted earnings rising to 87 cents compared to 3 cents in the prior year [5] - Over the past year, Suzano's shares have increased by 5.9%, while the industry has seen an 18.4% growth [6]
Suzano & Kimberly-Clark to Form Global Tissue Joint Venture